Skip to main content

Equibles does not estimate personal net worth.

Get an email with a short summary when Regeneron Pharmaceuticals, Inc. publishes a filing, an earnings call transcript or a press release.

Get REGN alerts

About Dr. Len Schleifer

Dr. Len Schleifer is recorded as CEO at Regeneron Pharmaceuticals, Inc. (REGN). Dr. Len Schleifer has spoken on 1 earnings call across 1 company, most recently for Regeneron Pharmaceuticals, Inc. on July 30, 2026. Regeneron Pharmaceuticals, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Regeneron Pharmaceuticals, Inc. includes George D. Yancopoulos, M.D., Ph.D. (Chairman), Leonard S. Schleifer, M.D., Ph.D. (Chairman), Joseph J. LaRosa (General Counsel) and 7 others.

Dr. Len Schleifer on recent calls

“Before we begin, I would like to acknowledge with deep sadness the passing earlier this week of financial industry luminary and long-time Regeneron director, Arthur Art Ryan.”
CEO, Regeneron Pharmaceuticals, Inc. Q2 FY2026 Earnings Call ·

Affiliation history

Company network

Leadership on record at Regeneron Pharmaceuticals, Inc.

Recent activity